"Weight Loss" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Decrease in existing BODY WEIGHT.
| Descriptor ID |
D015431
|
| MeSH Number(s) |
C23.888.144.243.963 G07.345.249.314.120.200.963
|
| Concept/Terms |
Weight Loss- Weight Loss
- Loss, Weight
- Losses, Weight
- Weight Losses
- Weight Reduction
- Reduction, Weight
- Reductions, Weight
- Weight Reductions
|
Below are MeSH descriptors whose meaning is more general than "Weight Loss".
Below are MeSH descriptors whose meaning is more specific than "Weight Loss".
This graph shows the total number of publications written about "Weight Loss" by people in this website by year, and whether "Weight Loss" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 3 | 4 |
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 5 | 6 |
| 1999 | 2 | 2 | 4 |
| 2000 | 1 | 2 | 3 |
| 2001 | 3 | 1 | 4 |
| 2002 | 3 | 1 | 4 |
| 2003 | 4 | 4 | 8 |
| 2004 | 0 | 3 | 3 |
| 2005 | 6 | 6 | 12 |
| 2006 | 8 | 9 | 17 |
| 2007 | 10 | 6 | 16 |
| 2008 | 10 | 8 | 18 |
| 2009 | 10 | 8 | 18 |
| 2010 | 12 | 8 | 20 |
| 2011 | 12 | 5 | 17 |
| 2012 | 11 | 10 | 21 |
| 2013 | 17 | 10 | 27 |
| 2014 | 8 | 14 | 22 |
| 2015 | 10 | 11 | 21 |
| 2016 | 6 | 7 | 13 |
| 2017 | 12 | 15 | 27 |
| 2018 | 4 | 4 | 8 |
| 2019 | 7 | 15 | 22 |
| 2020 | 10 | 3 | 13 |
| 2021 | 6 | 13 | 19 |
| 2022 | 5 | 13 | 18 |
| 2023 | 1 | 16 | 17 |
| 2024 | 5 | 9 | 14 |
| 2025 | 4 | 10 | 14 |
| 2026 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Weight Loss" by people in Profiles.
-
Associations among pork intake, weight-loss, and diet quality outcomes in a commercial weight-management program. Nutr Diabetes. 2026 05 29; 16(1).
-
Expert recommendations for preterm neonates' growth goals: Considerations for clinicians. Semin Perinatol. 2026 Jun; 50(4):152228.
-
Geroprotective effects of diet and exercise plus metformin in frail older veterans with obesity: The DEMFOS randomized trial protocol. Contemp Clin Trials. 2026 Jun; 165:108321.
-
Effect of a self-directed lifestyle-based weight management program among patients with comorbid COPD and sleep apnea: a secondary analysis of the INSIGHT COPD trial. Ann Am Thorac Soc. 2026 03 01; 23(3):419-428.
-
Real-World Evidence on Weight Loss and Safety With Semaglutide in Obesity Telehealth: A Large Retrospective Cohort Study. Obesity (Silver Spring). 2026 Mar; 34(3):729-737.
-
The Benefits of Exercise Training in Combination With Weight Loss Therapies. Diabetes. 2025 Dec 01; 74(12):2199-2206.
-
Baseline characteristics in the SYNCHRONIZE?-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes. Diabetes Obes Metab. 2026 02; 28(2):1490-1498.
-
Time to regain birthweight and in-hospital outcomes among United States-born extremely preterm newborns. Pediatr Res. 2026 Feb; 99(3):949-957.
-
Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE?-1). Diabetes Obes Metab. 2026 01; 28(1):337-346.
-
The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2026 Mar; 109(3):442-464.